HERON THERAPEUTICS INC earnings per share and revenue

AXD2 earnings per share for the last quarter are -0.02 EUR whereas the estimation was -0.07 EUR which accounts for 73.16% surprise. Company revenue for the same period amounts to 32.13 M EUR despite the estimated figure of 30.56 M EUR. Estimated earnings per share for the next quarter are -0.04 EUR, and revenue is expected to reach 33.69 M EUR. Also watch annual changes over time to get a bigger picture of AXD2 earnings per share and revenue dynamics.